Top in ID: Johnson & Johnson vaccine, COVID-19 vaccine rollout

Last week, the FDA said it will review Johnson & Johnson’s COVID-19 vaccine for emergency use, but it will not make a decision until after a meeting of the independent Vaccines and Related Biological Products Advisory Committee on Feb. 26.

The announcement was the top story in infectious disease last week. Other top stories focused on the need for a “multilayered approach” to COVID-19 vaccine rollout and the CDC’s efforts to slow the spread of COVID-19 on public transportation and in congregate settings.

Read these and more top stories in infectious disease below:

FDA will review one-shot Johnson & Johnson vaccine that ‘could be a game changer’

Johnson & Johnson has applied for emergency use authorization from the FDA for its one-shot COVID-19 vaccine, which experts have said could help change the trajectory of the pandemic. Read more.

‘Multilayered approach’ to COVID-19 still needed as vaccine rollout continues

It is still important for people who have been vaccinated against COVID-19 to wear masks and practice social distancing, experts said. Read more.

CDC mandates masks on public transit, extends eviction moratorium to slow COVID-19

To help slow the spread of COVID-19, the CDC has mandated that face masks be worn on all forms of public transportation and extended a moratorium on evictions to prevent homelessness and unnecessary congregate living. Read more.

NFL COVID-19 protocols have ‘broad and attainable implications’ for public

Intensive COVID-19 protocols helped reduce exposure to SARS-CoV-2 in the National Football League, according to a recent MMWR report. Read more.

Many ‘strong’ IDSA recommendations based on lower-quality evidence, analysis finds

Almost half of the recommendations graded as “strong” in 17 current Infectious Diseases Society of America clinical practice guidelines are based on lower-quality evidence, an analysis found. Read more.